# Bitter Gourd Seed Oil (Momordica charantia)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/bitter-gourd-seed-oil
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-25
**Evidence Score:** 2 / 10
**Category:** Seed Oils
**Also Known As:** Momordica charantia seed oil, BGSO, Karela seed oil, Balsam pear seed oil, Bitter melon seed oil, Ku gua seed oil, Ampalaya seed oil

## Overview

Bitter gourd seed oil (BGSO), extracted from Momordica charantia seeds, is rich in conjugated linolenic acid (CLnA), particularly α-eleostearic acid, which drives its anti-proliferative and gastroprotective effects. These bioactive fatty acids modulate apoptotic gene expression and reduce oxidative mucosal damage, making BGSO a subject of growing preclinical research.

## Health Benefits

• Anti-cancer properties: Preclinical studies show BGSO induces apoptosis in colon cancer cells through upregulation of GADD45 and p53 genes (in vitro evidence only)
• Anti-ulcer effects: Animal studies demonstrate gastroprotective effects at 10-100 mg/kg, reducing edema and mucosal damage in rats (preclinical evidence)
• [Antimicrobial](/ingredients/condition/immune-support) activity: Laboratory testing shows effectiveness against Streptococcus pyogenes at 1000 µg/mL (in vitro evidence only)
• Potential blood sugar support: While no human studies exist for the oil specifically, related bitter gourd fruit preparations show hypoglycemic effects (indirect evidence)
• Lipid [metabolism](/ingredients/condition/weight-management): Free fatty acids from BGSO reduce triglyceride accumulation in hepatoma cells (in vitro evidence only)

## Mechanism of Action

Bitter gourd seed oil exerts anti-cancer effects primarily through its high concentration of α-eleostearic acid (a conjugated linolenic acid), which upregulates pro-apoptotic genes GADD45 and p53, triggering mitochondria-mediated cell death in colon cancer cell lines. Its gastroprotective mechanism involves reduction of [pro-inflammatory cytokine](/ingredients/condition/inflammation)s (TNF-α, IL-6) and inhibition of [lipid peroxidation](/ingredients/condition/antioxidant) via antioxidant pathways, preserving gastric mucosal integrity. Additionally, CLnA isomers in BGSO may act as PPAR-γ ligands, influencing lipid [metabolism](/ingredients/condition/weight-management) and inflammatory signaling cascades.

## Clinical Summary

Current evidence for bitter gourd seed oil is limited to in vitro and animal models, with no published randomized controlled trials in humans. In vitro studies demonstrate dose-dependent apoptosis induction in HT-29 colon cancer cells via GADD45 and p53 upregulation, though these findings have not been replicated in human subjects. Animal studies using rat models report significant gastroprotective effects at doses of 10–100 mg/kg, including reduced gastric edema and mucosal lesion scores compared to controls. The totality of evidence is preliminary; human pharmacokinetic and efficacy data are currently absent, warranting caution before drawing clinical conclusions.

## Nutritional Profile

Bitter Gourd Seed Oil (BGSO) is a lipid-rich extract with a distinctive fatty acid profile dominated by conjugated linolenic acid (CLnA) isomers, particularly alpha-eleostearic acid (cis-9, trans-11, trans-13 octadecatrienoic acid) comprising approximately 50-60% of total fatty acids — a rare conjugated trienoic fatty acid also found in tung oil. Additional fatty acids include linoleic acid (omega-6, ~15-20%), oleic acid (omega-9, ~10-15%), stearic acid (~5-8%), and palmitic acid (~4-6%). The oil contains no significant protein, fiber, or carbohydrate content as it is a refined seed oil extract. Micronutrient content includes tocopherols (primarily gamma-tocopherol, ~200-400 mg/kg oil), functioning as endogenous [antioxidant](/ingredients/condition/antioxidant)s that contribute to oil stability. Bioactive compounds include momordicin-related triterpenoids carried in trace residual amounts from seed extraction, and phytosterols (beta-sitosterol being predominant, estimated ~1,000-2,500 mg/kg), which may contribute to cholesterol-modulating effects. The conjugated trienoic fatty acid alpha-eleostearic acid is considered the primary bioactive component responsible for documented biological activities. Bioavailability note: Alpha-eleostearic acid undergoes partial conversion to rumenic acid (CLA isomer) during intestinal absorption in mammals, which may partially mediate its bioactivity; absorption efficiency is enhanced when consumed with other dietary fats. Cold-pressed extraction preserves higher bioactive compound concentrations compared to solvent-extracted variants.

## Dosage & Preparation

No clinically studied dosages exist for bitter gourd seed oil in humans. Preclinical studies used 10-100 mg/kg body weight in rats. Related bitter gourd fruit powder has been studied at 2-2.5 g/day in humans. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Human safety data for isolated bitter gourd seed oil supplements is largely lacking, though the whole fruit of Momordica charantia is generally consumed safely as food across Asia and Africa. Animal studies suggest hepatotoxic potential at high doses, and the hypoglycemic properties of Momordica charantia compounds may potentiate [blood glucose](/ingredients/condition/weight-management)-lowering medications such as metformin or insulin, risking additive hypoglycemia. BGSO is contraindicated during pregnancy due to documented uterotonic and abortifacient effects of Momordica charantia constituents in animal models. Individuals with G6PD deficiency should exercise caution, as favism-like reactions have been reported with related Momordica preparations.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses have been conducted specifically on bitter gourd seed oil. Evidence is limited to preclinical studies, including in vitro cancer cell research and rat models for anti-ulcer effects at 10-100 mg/kg doses. Human studies exist only for other forms of bitter gourd, such as fruit powder at 2-2.5 g/day showing [blood glucose](/ingredients/condition/weight-management) effects.

## Historical & Cultural Context

Bitter gourd seed oil from Momordica charantia has been used in folk medicine worldwide for diabetes, cancer, [inflammatory](/ingredients/condition/inflammation) diseases, jaundice, leprosy, piles, psoriasis, and rheumatism. Traditional applications also include use as a birth control and abortion agent, indicating its potent biological activity.

## Synergistic Combinations

Alpha-lipoic acid, Chromium picolinate, Cinnamon extract, Turmeric, Black pepper extract

## Frequently Asked Questions

### What is α-eleostearic acid and why does it matter in bitter gourd seed oil?

α-Eleostearic acid is a conjugated linolenic acid (CLnA) isomer that constitutes approximately 50–60% of bitter gourd seed oil's fatty acid profile. It is the primary bioactive compound responsible for BGSO's anti-proliferative effects, as it triggers apoptosis in cancer cell lines by upregulating p53 and GADD45 tumor suppressor genes. This fatty acid also exhibits antioxidant activity that contributes to the oil's documented gastroprotective properties in rodent models.

### Can bitter gourd seed oil help fight cancer?

Preclinical in vitro research shows that bitter gourd seed oil induces apoptosis in HT-29 colon cancer cells through upregulation of the apoptotic genes GADD45 and p53, suggesting anti-proliferative potential. However, all current evidence is limited to cell culture experiments, and no human clinical trials have been conducted to confirm these effects in cancer patients. It is not an approved cancer treatment, and patients should not substitute it for evidence-based oncology care.

### What dose of bitter gourd seed oil was used in animal ulcer studies?

Animal studies investigating the gastroprotective effects of bitter gourd seed oil used doses ranging from 10 to 100 mg/kg body weight in rat models of induced gastric ulceration. At these doses, researchers observed significant reductions in gastric edema, mucosal lesion scores, and markers of lipid peroxidation compared to untreated controls. No equivalent human dose has been established, as clinical trials in humans have not yet been performed.

### Is bitter gourd seed oil safe to take during pregnancy?

Bitter gourd seed oil is not considered safe during pregnancy based on available evidence. Compounds from Momordica charantia, including momordicin and related glycosides present in seed preparations, have demonstrated uterotonic and abortifacient effects in animal studies. Pregnant women should avoid BGSO supplements until human safety data are available, and should consult a healthcare provider before using any Momordica charantia product.

### Does bitter gourd seed oil interact with diabetes medications?

Bitter gourd seed oil and related Momordica charantia preparations contain bioactive compounds—including charantin and polypeptide-p—with documented hypoglycemic activity that may potentiate the effects of antidiabetic drugs such as metformin, glipizide, or insulin. Combining BGSO with these medications could result in additive blood glucose lowering and increase the risk of hypoglycemia. Diabetic patients using glucose-lowering pharmacotherapy should consult their physician before adding any Momordica charantia supplement to their regimen.

### What is the most bioavailable form of bitter gourd seed oil, and does extraction method affect its potency?

Cold-pressed bitter gourd seed oil preserves heat-sensitive compounds like α-eleostearic acid and polyphenols better than solvent extraction methods. The presence of natural lipid carriers in whole seed oil may enhance absorption of fat-soluble bioactive compounds compared to isolated extracts. However, no direct human bioavailability studies comparing extraction methods currently exist for this ingredient.

### How strong is the current scientific evidence for bitter gourd seed oil's health benefits?

Most evidence for bitter gourd seed oil remains preclinical, limited to in vitro cell studies and animal models in rats and mice. While anti-cancer and anti-ulcer effects show promise in laboratory settings, no large-scale human clinical trials have been completed to confirm efficacy or optimal dosing in people. The antimicrobial properties have been demonstrated in laboratory testing, but clinical relevance in human infections remains unclear.

### Who would benefit most from bitter gourd seed oil supplementation, and who should avoid it?

Individuals with poor glucose control who are not taking diabetes medications may theoretically benefit, though clinical evidence in humans is limited. People with active gastrointestinal ulcers should consult a healthcare provider before use, as most gastroprotective data comes from animal prevention studies rather than treatment of established disease. Those taking blood-thinning medications should use caution, as some seed oils contain compounds affecting platelet function, though bitter gourd seed oil's specific effects require further study.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*